Voyager raises $60M in series B

Voyager Therapeutics Inc. (Cambridge, Mass.) raised $60 million in an untranched series B round led by new investors Brookside Capital and Partner Fund Management. Wellington Management; Casdin Capital; and two undisclosed funds also invested.

A Voyager spokesperson said the participation of crossover investors "could help support a future potential IPO," but declined to discuss the company's plans for going public. ...